Introduction
Children exposed to secondhand smoke (SHS) are at increased risk of respiratory illnesses. We piloted a Smoke Free Intervention (SFI) and trial methods before investigating its effectiveness and cost-effectiveness in...
Post-release opioid-related overdose mortality is the leading cause of death among people released from jails or prisons (PRJP). Informed by the proximate determinants framework, this paper presents the Post-Release Opioid-Related...
General practitioners (GPs) play an important role in the physical care of patients with severe mental illness, so our aim was to analyse the relationships between GPs’ sociodemographic status and worked-related...
How therapists can build and manage the recovery-promoting relationship with the client is the focus of this third bulletin recapping 16 reviews for the American Psychological Association, each featuring expert advice based on amalgamations...
In collaboration with the Ministry of Health of the Government of Serbia, UNODC supported the implementation of the UNODC/WHO substance use disorder treatment facility survey to map existing treatment capacity. The results of the survey...
Medication of the type heralded as a possible “game-changer” by one of the UK’s leading addiction treatment clinicians and researchers proved its worth in a US placebo-controlled trial. Buprenorphine injections with effects lasting a month...
Cognitive impairments in substance use disorder predict treatment outcome and are assumed to differ between substances. They often go undetected, thus the current study focuses on the prevalence of and...
People who have experienced serious mental health issues are three times more likely to smoke than the wider population.
This summary, plus infographic, describes the Smoking Cessation Intervention for People with Severe Mental Ill Health...
